In addition to six poster presentations, Ovation scientists are leading several sessions and programs at this year’s virtual event for reproductive experts.
Matthew “Tex” VerMilyea, PhD, HCLD/CC, Vice President of Scientific Advancement, Ovation Fertility
Los Angeles, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Ovation® Fertility is once again proving its status as a prolific producer of research in the field of reproductive medicine, with six abstracts accepted for poster presentations at the ASRM 2020 Scientific Congress and Expo, the premier conference for reproductive experts, taking place October 17-21, 2020. Additionally, Ovation scientists are leading several interactive sessions and roundtable discussions at the virtual event.
“Ovation is once again honored to get to participate in ASRM and play a leading role in advancing the state of the art in IVF,” says Matthew “Tex” VerMilyea, PhD, HCLD/CC, vice president of scientific advancement. “This year’s ASRM Congress is taking place online for obvious reasons, but the global pandemic has not stopped Ovation scientists from collaborating on their ongoing research while supporting physicians and patients across our network of nine nationwide IVF labs. We are eager to share our findings with other IVF researchers and fertility specialists, so that more hopeful parents can benefit from the latest scientific advances to grow their families.”
The list of Ovation abstracts and presentations accepted for ASRM 2020 covers a wide range of topics of importance to IVF scientists worldwide.
Presentations and Sessions:
CME Interactive Session: Benefits and Limitations of Time Lapse Imaging and AI in ART. T. Arthur Chang, PhD, HCLD, ELD, (Chair) University of Texas Health Science Center; Eva Schenkman, MS, CCRM; Matthew David VerMilyea, Ph.D., Ovation Fertility.
RD2-18 Roundtable Discussion: PGT Technologies: How to Know What Is Safe and Effective for Your Patients. Amy Jones, MS, Ovation Fertility.
RD5-10 IVF Roundtable Discussion: Add-ons: Patient Driven or Financially Motivated. Matthew VerMilyea, PhD, Ovation Fertility.
P-46: Stage of Transferred Blastocyst May Affect Pregnancy Outcomes When Timed with Endometrial Receptivity Assay (ERA). Rae vanTol, BS1; Robert Colver, MD2; Bradford Bopp, MD2; Matthew Will, MD2; Erica Anspach Will, MD2; Glen Adaniya, PhD1. 1Ovation Fertility, Indianapolis, Indiana; 2Midwest Fertility Specialists, Carmel, Indiana.
P-92: Evidence for Superior Blastocyst Cohort Ranking Using Artificial Intelligence Based on Retrospective Clinical Pregnancy Results. Matthew David VerMilyea, PhD1; Milad A Dakka, PhD2; Jonathan MM Hall, PhD3; Sonya M Diakiw, PhD2; Tuc Van Nguyen, PhD2; Don Perugini, PhD2; Kaylen Silverberg, MD4; Michelle Perugini, PhD2. 1Ovation Fertility, San Antonio, Texas; 2Presagen and Life Whisperer, Adelaide, SA, Australia; 3Australian Research Council Centre of Excellence for Nanoscale Biophotonics, Adelaide, SA, Australia.
P-100: Identifying Inherent Poor Quality Embryo Data Using Artificial Intelligence to Improve AI Performance and Clinical Reporting. Milad A Dakka, PhD1; Matthew David VerMilyea, PhD2; Tuc Van Nguyen, PhD1; Don Perugini, PhD1; Sonya M Diakiw, PhD1; Kaylen Silverberg, MD3; Jonathan MM Hall, PhD4; Michelle Perugini, PhD1. 1Presagen and Life Whisperer, Adelaide, SA, Australia; 2Ovation Fertility, San Antonio, Texas; 3Texas Fertility Center, Austin, Texas; 4Australian Research Council Centre of Excellence for Nanoscale Biophotonics, Adelaide, SA, Australia.
P-135: Alternative Blastocyst Vitrification Warming-Dilution Approaches: Do Virtues of the Kiss Principle Apply? Mitchel C. Schiewe, PhD, HCLD (ABB)1; Tannia Ochoa, BA1; Casey Zeffiro, BA, BS, MS1; Shane Zozula, BS, TS (ABB)1; James Stachecki, PhD2. 1Ovation Fertility, Newport Beach, California; 2Innovative Cryo Enterprises LLC, Linden, New Jersey.
P-190: Status Quo – Or Is It Time to Reconsider the Vitrification Method Relative to the Risk of Embryo Disease Transmission in Cryostorage? Mitchel C. Schiewe, PhD, HCLD (ABB)1; Shane Zozula, BS, TS (ABB)1; Nancy L. Nugent, MS1; James Stachecki, PhD2; Robert E. Anderson, MD3. 1Ovation Fertility, Newport Beach, California; 2Innovative Cryo Enterprises LLC, Linden, New Jersey; 3SCCRM, Newport Beach, California.
P-456: The Degree of Blastocyst Expansion Post-Warming Strongly Predicts Clinical Outcomes in Single Frozen Embryo Transfer Cycles (SFET). Ahmad Morsi Abu Maizar, MSc1; Diane Wright, PhD2; Richard Marrs, MD1; Guy E Ringler, MD1; Kelly J Baek, MD1; Karine Chung, MD1; Matthew David VerMilyea, PhD3. 1California Fertility Partners, Los Angeles, California; 2Ovation Fertility, Houston, Texas; 3Ovation Fertility, San Antonio, Texas.
Ovation research presented at ASRM 2020 will be available at www.OvationFertility.com/research.
About Ovation Fertility
Ovation® Fertility is a national network of reproductive endocrinologists and scientific thought leaders focused on reducing the cost of having a family through more efficient and effective fertility care. Ovation’s IVF and genetics laboratories, along with affiliated physician practices, work collaboratively to raise the bar for IVF treatment, with state-of-the-art, evidence-based fertility services that give hopeful parents the best chance for a successful pregnancy. Physicians partner with Ovation to offer their patients advanced preconception carrier screening; preimplantation genetic testing; donor egg and surrogacy services; and secure storage for their frozen eggs, embryos and sperm. Ovation also helps IVF labs across America improve their quality and performance with expert off-site lab direction and consultation. Learn more about Ovation’s vision of a world without infertility at www.OvationFertility.com.
CONTACT: Amy Hall Ovation Fertility 214.893.8214 AHall@OvationFertility.com